Okano S, Tahara M, Tsukahara K, Otsuka T, et al. Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial. J Clin Oncol 2026;44:2602-2613.
PMID: 42546251